- Home
- CYCC vs RAND Comparison
CYCC vs RAND Comparison
Compare CYCC & RAND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CYCC
- RAND
- Stock Information
- Founded
- CYCC 1992
- RAND 1969
- Country
- CYCC Malaysia
- RAND United States
- Employees
- CYCC N/A
- RAND N/A
- Industry
- CYCC Biotechnology: Pharmaceutical Preparations
- RAND Finance: Consumer Services
- Sector
- CYCC Health Care
- RAND Finance
- Exchange
- CYCC Nasdaq
- RAND Nasdaq
- Market Cap
- CYCC 47.6M
- RAND 52.9M
- IPO Year
- CYCC N/A
- RAND N/A
- Fundamental
- Price
- CYCC $0.35
- RAND $18.21
- Analyst Decision
- CYCC Strong Buy
- RAND
- Analyst Count
- CYCC 1
- RAND 0
- Target Price
- CYCC $11.00
- RAND N/A
- AVG Volume (30 Days)
- CYCC 7.1M
- RAND 6.3K
- Earning Date
- CYCC 05-13-2025
- RAND 05-05-2025
- Dividend Yield
- CYCC 43.71%
- RAND 6.03%
- EPS Growth
- CYCC N/A
- RAND 39.63
- EPS
- CYCC N/A
- RAND 3.11
- Revenue
- CYCC $43,000.00
- RAND $8,499,970.00
- Revenue This Year
- CYCC $137.21
- RAND N/A
- Revenue Next Year
- CYCC N/A
- RAND N/A
- P/E Ratio
- CYCC N/A
- RAND $6.24
- Revenue Growth
- CYCC N/A
- RAND 12.52
- 52 Week Low
- CYCC $0.17
- RAND $13.82
- 52 Week High
- CYCC $4.00
- RAND $31.89
- Technical
- Relative Strength Index (RSI)
- CYCC 65.97
- RAND 42.03
- Support Level
- CYCC $0.23
- RAND $18.00
- Resistance Level
- CYCC $0.30
- RAND $19.70
- Average True Range (ATR)
- CYCC 0.06
- RAND 0.94
- MACD
- CYCC 0.01
- RAND 0.05
- Stochastic Oscillator
- CYCC 68.57
- RAND 6.36
About CYCC Cyclacel Pharmaceuticals Inc.
Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company that develops targeted medicines for cancer and other proliferative diseases. The company develops several families of anticancer drugs that act on the cell cycle, including CDK (cyclin-dependent kinase) inhibitors and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include fadraciclib and plogosertib.
About RAND Rand Capital Corporation
Rand Capital Corp is a closed-end, externally managed, non-diversified investment company. The company's investment objective is to generate current income and, when possible, complement its current income with capital appreciation by focusing its debt and related equity investments in privately-held, lower middle market companies with committed and experienced managements in a broad variety of industries. It predominantly invests in higher-yielding debt instruments.